Zhongnan Medical Journal Press

Home Results

A total of 5 result was found. Results that relate to LI Jie

Romiplostim for the treatment of primary immune thrombocytopenia in adults: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(8):909-918.
15551 times 3634 times

LI Jie XIE Jun HAN Yi MENG Ying GAO Liyuan SHI Xiaohui JIANG Zhitao

Romiplostim Primary immune thrombocytopenia Efficacy Safety Economic Rapid health technology assessment
Details
A case report of psoriasis-like rash caused by tislelizumab

Published on Chinese Journal of Pharmacoepidemiology 2024,33(10):1189-1195.
14222 times 3141 times

LI Jie WANG Ronghua XIE Xiaolei

Tislelizumab Psoriasis-like rash Adverse drug reaction
Details
Signals mining and analysis of adverse drug events in minors using recombinant human growth hormone based on the FAERS database

Published on Chinese Journal of Pharmacoepidemiology 2025,34(2):157-165.
14499 times 2471 times

DONG Jiaxiao WANG Yilei LI Xiuzheng LI Jie XU Yichun XU Xiaodong

Recombinant human growth hormone Data mining Adverse drug events Minors Pharmacovigilance
Details
Stomatitis caused by linagliptin tablet: a case report

Published on Chinese Journal of Pharmacoepidemiology 2025,34(7):841-844.
13271 times 2284 times

LI Jie LIU Xiaoyan HAN Yi

Linagliptin Ulcerative stomatitis Adverse drug reactions
Details
Disease burden of metabolic dysfunction-associated steatotic liver disease in the elderly population globally and in China from 1990 to 2021

Published on New Medicine 2026,36(4):428-437.
3566 times 1157 times

ZHANG Qiang ZHAO Xiaoxiao WANG Haibo XU Peng WANG Yaxing ZHAO Xinke LIU Fan LI Jiali HE Tao CHEN Zhengtao Ding Yunhan KE Lixin LI Jieyun XUN Yangqin LU Cuncun

Metabolic dysfunction-associated steatotic liver disease Non-alcoholic fatty liver disease Older adult Disease burden Prediction model
Details